XBiotech (XBIT)

• Market cap: $113M
• 1 day: -3.64%
• 5 days: -12.71%
• 1 month: -46.39%
• 3 months: -51.82%
• 6 months: -41.02%
• Year to date: -11.03%
• 1 year: -29.20%
• 5 years: -84.75%
• 10 years: -84.04%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Employees: 92

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

214% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 7

167% more call options, than puts

Call options by funds: $8K | Put options by funds: $3K

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

58% more capital invested

Capital invested by funds: $23.8M [Q2] → $37.6M (+$13.8M) [Q3]

9% more funds holding

Funds holding: 46 [Q2] → 50 (+4) [Q3]

0.77% more ownership

Funds ownership: 15.18% [Q2] → 15.96% (+0.77%) [Q3]